# Zhengye Biotechnology Holding Limited (ZYBT)

Source: https://www.quantisnow.com/company/ZYBT
Generated: 2026-11-20T05:39:05.806Z

- Ticker: ZYBT
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2025
- SEC CIK: 0001975641

## Latest ZYBT news and filings

- 2026-11-12 21:30 UTC [Public Offering] [Zhengye Biotechnology Holding Limited Announces Financial Results for the First Six Months of Fiscal Year 2026](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-announces-financial-results-for-the-first-6788361)
- 2026-11-12 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-zhengye-biotechnology-holding-limited-6787972)
- 2026-08-06 20:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-zhengye-biotechnology-holding-limited-6669055)
- 2026-08-06 12:00 UTC [Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-regains-compliance-with-nasdaq-bid-price-6667394)
- 2026-07-21 20:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-zhengye-biotechnology-holding-limited-6643822)
- 2026-07-21 12:30 UTC [Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-comments-on-unusual-trading-activity-6643372)
- 2026-06-25 15:41 UTC [SEC Form 3] [New insider Han Zhenfa claimed ownership of 42,963,748 units of Ordinary shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-han-zhenfa-claimed-ownership-of-42963748-units-of-6615503)
- 2026-06-25 15:41 UTC [SEC Form 3] [SEC Form 3 filed by new insider Cheng Yuhong (Nmn)](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-cheng-yuhong-nmn-6615502)
- 2026-06-25 15:40 UTC [SEC Form 3] [SEC Form 3 filed by new insider Song Songlin](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-song-songlin-6615499)
- 2026-06-25 15:39 UTC [SEC Form 3] [SEC Form 3 filed by new insider Wang Ping (Nmn)](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-wang-ping-nmn-6615498)
- 2026-06-25 15:38 UTC [SEC Form 3] [SEC Form 3 filed by new insider Jiang Ping (Piji)](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-jiang-ping-piji-6615494)
- 2026-06-04 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-zhengye-biotechnology-holding-limited-6589260)
- 2026-06-04 20:05 UTC [Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-receives-nasdaq-notification-regarding-minimum-bid-6589213)
- 2026-04-28 20:31 UTC [SEC Form 20-F filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-zhengye-biotechnology-holding-limited-6519093)
- 2026-04-28 20:30 UTC [Public Offering] [Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-announces-fiscal-year-2025-financial-results-6519029)
- 2026-04-24 22:39 UTC [SEC Form 3] [SEC Form 3 filed by new insider Hu Qiyi](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-hu-qiyi-6515128)
- 2026-04-24 22:39 UTC [SEC Form 3] [SEC Form 3 filed by new insider Li Guohan (Nmn)](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-li-guohan-nmn-6515127)
- 2026-04-06 13:25 UTC [Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-announces-implementation-of-dual-class-share-structure-6488937)
- 2026-03-18 20:10 UTC [SEC Form 3] [SEC Form 3 filed by new insider Lian Wei](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-lian-wei-6457822)
- 2026-03-18 20:10 UTC [SEC Form 3] [SEC Form 3 filed by new insider Liu Zhongyao](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-liu-zhongyao-6457821)
- 2026-03-18 20:10 UTC [SEC Form 3] [SEC Form 3 filed by new insider Sun Wenhua](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-sun-wenhua-6457820)
- 2026-03-18 20:10 UTC [SEC Form 3] [SEC Form 3 filed by new insider Han Aiden](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-han-aiden-6457819)
- 2026-02-23 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-zhengye-biotechnology-holding-limited-6407189)
- 2026-02-10 13:30 UTC [Public Offering] [Zhengye Biotechnology Holding Limited Issues 2026 Chairman's Letter to Shareholders](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-issues-2026-chairmans-letter-to-shareholders-6383217)
- 2025-12-12 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-zhengye-biotechnology-holding-limited-6314120)
- 2025-07-03 12:30 UTC [Public Offering] [Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-announces-fiscal-year-2024-financial-results-6110164)
- 2025-07-03 10:30 UTC [SEC Form 20-F filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-zhengye-biotechnology-holding-limited-6110021)
- 2025-05-23 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-zhengye-biotechnology-holding-limited-6056485)
- 2025-05-23 20:05 UTC [Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-F](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-receives-nasdaq-notice-related-to-late-6056466)
- 2025-04-29 20:00 UTC [SEC Form NT 20-F filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-nt-20-f-filed-by-zhengye-biotechnology-holding-limited-6006954)
- 2025-03-06 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-zhengye-biotechnology-holding-limited-5930970)
- 2025-01-14 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-zhengye-biotechnology-holding-limited-5845533)
- 2025-01-14 17:00 UTC [Public Offering] [Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-announces-full-exercise-of-underwriters-over-allotment-5845269)
- 2025-01-08 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Zhengye Biotechnology Holding Limited](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-zhengye-biotechnology-holding-limited-5839653)
- 2025-01-08 17:00 UTC [Public Offering] [Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering](https://www.quantisnow.com/insight/zhengye-biotechnology-holding-limited-announces-closing-of-initial-public-offering-5839273)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ZYBT
- Earnings history: https://www.quantisnow.com/earnings/ZYBT
- Dividend history: https://www.quantisnow.com/dividends/ZYBT
- Insider transactions: https://www.quantisnow.com/insiders/ZYBT
- Options chain: https://www.quantisnow.com/options/ZYBT
- SEC 8-K filings only: https://www.quantisnow.com/company/ZYBT/8-k
- RSS and alerts for ZYBT: https://www.quantisnow.com/docs/rss-feeds.md
